Volume 4; Issue 1 Suppleme

Main
Cancer Cell International
Volume 4; Issue 1 Suppleme

Cancer Cell International

Volume 4; Issue 1 Suppleme

1

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes

R Weth, M Biburger, W Wels

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

2

Adoptive T cell therapy using antigen-specific CD8+T cells for the treatment of patients with metastatic melanoma: a phase I clinical study

N Meidenbauer, S Vogl, M Laumer, J Heymann, R Andreesen, A Mackensen

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 195 KB

english, 2004

3

Large scalein vitroexpansion of polyclonal human CD4+CD25highregulatory T cells

P Hoffmann, R Eder, LA Kunz-Schughart, R Andreesen, M Edinger

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

4

Reversible HLA multimers (streptamers) for isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens

J Neudorfer, B Schmidt, K Huster, M Schiemann, T Schmidt, H Wagner, C Peschel, DH Busch, H Bernhard

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 416 KB

english, 2004

5

Therapeutic efficacy of RAGE-1 and MAGE-9 peptide specific cytotoxic T cell clones in renal cell carcinoma

N Oehlrich, M Linnebacher, S Stevanovic, M Zoeller

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 192 KB

english, 2004

6

The role of glycosylation as a modulator for signalling strength in T cells

B Hauptrock, J Kuball, R-H Voss, M Brkic, C Huber, M Theobald

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 191 KB

english, 2004

7

Migration of dendritic cells to regional lymph nodes in a vaccination trial

A Riccobon, R Ridolfi, R Galassi, M Petrini, M Stefanelli, L Fiammenghi, G Giorgetti, A Moretti, L Ridolfi, G Fiorentini

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 200 KB

english, 2004

8

Transitory response to vaccination with PSCA-/PSA-peptide loaded, autologous dendritic cells in patients with metastatic, hormone-refractory prostate cancer

AK Kaskel, R Zeiser, R Jochim, W Schultze-Seemann, CF Waller, H Veelken

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 194 KB

english, 2004

9

Vaccination with WT1 induces high frequency memory and effector T cells in peripheral blood and bone marrow associated with complete remission of recurrent AML

A Letsch, C Scheibenbogen, AM Asemissen, V Mailänder, E Thiel, U Keilholz

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 199 KB

english, 2004

10

LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers

A Bender, J Karbach, A Neumann, M Biskamp, D Jäger, S Gnjatic, E Hoffman, LJ Old, A Knuth, E Jäger

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

11

Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 189 KB

english, 2004

12

Antibody-based immunoreceptors: the impact of signalling domain, binding affinity and costimulation

A Hombach, C Heuser, H Abken

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 204 KB

english, 2004

13

Limiting the risk of immunogenicity by identification and removal of T-cell epitopes (DeImmunisation™)

K Hellendoorn, T Jones, J Watkins, M Baker, A Hamilton, F Carr

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 194 KB

english, 2004

14

Proteasome inhibition enhances HLA-class-II antibody-dependent polymorphonuclear cell mediated cytotoxicity against B-cell lymphoma

B Stockmeyer, M Gramatzki, R Repp

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 200 KB

english, 2004

15

Increased effector functions of a monoclonal antibody by glycoform engineering

G Waxenecker, M Schuster, P Umana, P Brünker, I Froihofer, S Wiederkum, C Schwager, H Klug, GC Mudde, G Himmler, H Loibner

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 194 KB

english, 2004

16

Inhibition of signaling via erbB-receptors by antibodies that target the Lewis Y-antigen

G Waxenecker, M Klinger, H Farhan, M Freissmuth, G Himmler, E Janzek, GC Mudde, H Loibner

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 192 KB

english, 2004

17

Release of iC3b from apoptotic pancreatic tumor cells induces tolerance by binding to immature dendritic cells

J Schmidt, MW Büchler, A Märten

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 190 KB

english, 2004

18

Bisphosphonic acid acts as Gamma/Delta T cell activating antigen and has direct cytotoxic activity against pancreatic carcinoma cells

J Schmidt, Mv Lilienfeld-Toal, MW Büchler, A Märten

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

19

Regulation of p53 tumor specific immune responses in colorectal cancer patients

M Büter, M Gasser, T Mueller, D Meyer, N Schramm, A Müller, A Trumpfheller, S Müller, A Thiede, AM Waaga-Gasser

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 199 KB

english, 2004

20

Assessment of genes associated with immune activation and regulation in pancreatic cancer patients

M Gasser, TF Mueller, A Müller, M Becker, N Schramm, M Büter, AM Gassel, A Thiede, H-J Gassel, AM Waaga-Gasser

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

21

Modulation of tumour directed B cell responses by NK cells

M Jensen, A Buhl, C Hoyer, S Schmitz, S Tawadros, H Harald-Sedlacek, J Schultze, F Berthold

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 195 KB

english, 2004

22

NFκB activation and TGFβ loss signatures are prominentex vivoresponses of peripheral blood mononuclear cells

T Zander, D Re, S Beyer, M Hellmich, A Popov, I Büchmann, J Wolf, S Debey, JL Schultze

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 427 KB

english, 2004

23

Tolerability and efficacy of the trifunctional antibody removab®(anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

P Wimberger, A Burges, V Gorbounova, H Sommer, B Schmalfeldt, J Pfisterer, M Lichinitser, A Makhson, M Ströhlein, W Eiermann, M Biakhov, V Moiseenko, A du Bois, R Kimmig

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 424 KB

english, 2004

24

Enrichment of functional CD8 memory T cells specific for MUC1 in Bone Marrow of Multiple Myeloma Patients

M Witzens, C Choi, M Bucur, M Feuerer, N Sommerfeldt, A Trojan, A Ho, V Schirrmacher, H Goldschmidt, P Beckhove

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 203 KB

english, 2004

25

Isolated γδ T cells express natural cytotoxicity receptors

M von Lilienfeld-Toal, J Nattermann, G Feldmann, IGH Schmidt-Wolf

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 204 KB

english, 2004

26

The kinetics of accumulation of adoptively transferred ovalbumin-specific T cells in a transgenic, ovalbumin-expressing murine tumor

R Agger, MS Petersen, CC Fleischer, ME Hokland

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 190 KB

english, 2004

27

Tumor-specific murine T cell receptors displace endogenous TCRs in human T cells

R-H Voss, S Thomas, J Kuball, R Engel, M Brkic, P Guillaume, P Romero, C Huber, M Theobald

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 422 KB

english, 2004

28

Induction of leukemia reactive, allogeneic donor lymphocytes

AK Kaskel, T Portugal, H Veelken, J Finke

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 412 KB

english, 2004

29

Identification of a melanoma-associated chondroitin sulfate proteoglycan (MCSP) peptide recognized by CD4+T lymphocytes on human melanoma cells

CS Erfurt, C Heirman, K Thielemans, G Schuler, ES Schultz

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 191 KB

english, 2004

30

Chimeric carrier proteins for targeted delivery of tumor antigens to professional antigen presenting cells

F Rohrbach, R Weth, M Kursar, H-W Mittrücker, W Wels

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

31

Particulate antigenic structures: highly immunogenic carriers for T cell epitopes derived from tumour antigens

M Brinkman, J Walter, S Grein, MJW Thies, C Reiser, J Hess

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

32

Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

B Gückel, S Stumm, C Rentzsch, S Kayser, I Gruber, A Marmé, J Huober, F Autschbach, S Meuer, D Wallwiener

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 424 KB

english, 2004

33

Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial

B Hildenbrand, A Langenkamp, B Sauer, C Stoll, O Constantiniu, R Leo, C Unger, M Azemar

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 200 KB

english, 2004

34

HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy

Y Wachter, J Brünke, S Schuster, K Barbin, M Peipp, T Valerius, M Gramatzki, G Fey, R Repp

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

35

The European Searchable Tumour Cell and Databank, ESTDAB, as a tool for research in cancer immunology

L Müller, D Schadendorf, S Stevanovic, A Knights, E Badalian, L Wedel, G Pawelec

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 417 KB

english, 2004

36

Efficientin vitroexpression of human reverse transcriptase (hTERT) in dendritic cells of lung cancer patients using RNA electrotransfection

A-K Brill, W Klapper, U Weingartz, I Bolz, A Heiser, D Kabelitz, M Kneba, B Gahn

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

37

Parvovirus H1-induced tumor cell death enhances human immune response via crosspresentation of dendritic cells

M Zeidler, J Cornelis, T Woelfel, J Rommeleare, PR Galle, M Heike, M Moehler

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

38

Optimizing the antigen loading of dendritic cells with exogenous peptides

ES Schultz, D Dieckmann, B Ring, G Schuler

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 187 KB

english, 2004

39

Phase I/II study of vaccination with immature and mature dendritic cells in patients with melanoma and renal cell carcinoma

M Petrini, L Fiammenghi, L Ridolfi, M Stefanelli, G Migliori, C Brolli, A Riccobon, R Ridolfi

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 200 KB

english, 2004

40

Survival and homing ofex vivoexpanded donor derived dendritic cells after allogeneic BMT

C Schimmelpfennig, S Schulz, C Arber, J Baker, I Tarner, J McBride, CG Fathman, C Contag, R Negrin

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 197 KB

english, 2004

41

PBMCs transfected with RNActive stimulate specific T-cells

R Teufel, J-P Carralot, B Scheel, I Hörr, Steve Pascolo

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 191 KB

english, 2004

42

Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patientsin vivo: results from a randomized clinical trial of IL-2 with or without histamine (MP 104)

AM Asemissen, C Scheibenbogen, A Letsch, K Hellstrand, K Gehlsen, E Thiel, U Keilholz

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 204 KB

english, 2004

43

Peptide vaccination induces specific effector and memory T cells but fails to enhance preexisting T cell immunity

A Letsch, U Keilholz, D Nagorsen, AM Asemissen, E Thiel, C Scheibenbogen

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 198 KB

english, 2004

44

Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines

MS von Bergwelt-Baildon, B Maecker, F Fiore, LM Nadler, JL Schultze

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 422 KB

english, 2004

45

Increased frequency of CTLA4+TGFβ+CD4+CD25+T cells in peripheral blood of patients with chronic lymphatic leukemia and multiple myeloma

M Beyer, M Kochanek, M von Bergwelt-Baildon, A Popov, J Wolf, JL Schultze

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

46

Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity

Ashley Knights, Stephanie McArdle, Ludmila Müller, Robert Rees, Graham Pawelec

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 191 KB

english, 2004

47

New TRP-2-derived T helper epitopes identified in HLA-DRB10301 transgenic mice elicit spontaneous T cell responses in HLA-DRB103 and HLA-DRB1*04 melanoma patients

M Song, W Osen, D Thomas, N Daniel, XD Nguyen, J Mueller-Berghaus, H Kropshofer, D Schadendorf, A Paschen

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

48

Use of immunopotentiating reconstituted influenza virosomes (IRIV) as vector to deliver antigens into dendritic cells

C Boccaccio, M Amacker, S Martin, M-T Duffour, J-P Abastado, R Zurbriggen, M Salcedo

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 199 KB

english, 2004

49

Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene

P Öhlschläger, M Pes, W Osen, M Dürst, A Schneider, L Gissmann, AM Kaufmann

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 202 KB

english, 2004

50

Immunomediated growth and regression of pancreatic tumorsin vivo

TF Greten, AI Garbe, FR Greten, F Korangy, MP Manns

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

51

The receptor for hyaluronic acid mediated motility (RHAMM/CD168) is a leukemia associated antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML)

J Greiner, M Ringhoffer, L Li, T Barth, T Wölfel, H Döhner, M Schmitt

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 192 KB

english, 2004

52

Sphingosine-kinase and sphingosine-1-phosphate regulate migration of immature dendritic cells

V Jakl, S Eigenbrod, R Derwand, M Dauer, S Endres, A Eigler

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 201 KB

english, 2004

53

Immunization of Rhesus monkeys with a conjugate vaccine IGN402 induces immune responses against carbohydrate and protein antigens, and cancer cells

G Waxenecker, R Kircheis, P Vondru, I Zinöcker, D Häring, D Krey, A Nechansky, GC Mudde, G Himmler, H Loibner

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 190 KB

english, 2004

54

The Tübingen approach: identification, selection and validation of tumor-associated HLA peptides for cancer therapy

H Singh, T Weinschenk, C Lemmel, O Schoor, J Dengjel, C Gouttefangeas, S Stevanovic, P Brossart, H-G Rammensee

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 192 KB

english, 2004

55

Molecular characterization of virus-induced autoantibody responses

P Krebs, B Ludewig, Metters, Ö Türeci, U Sahin

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 190 KB

english, 2004

56

MMP-7 inhibits CTL – tumor cell interaction

S Gregor, V Alla, J Kuball, M Theobald, PR Galle, D Strand, S Strand

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 189 KB

english, 2004

57

Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM

C Uherek, T Müller, T Tonn, B Uherek, H-G Klingemann, WS Wels

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 193 KB

english, 2004

58

Rapid functional exhaustion and deletion of cytotoxic T lymphocytes following immunization with recombinant adenovirus

E Scandella, P Krebs, B Odermatt, B Ludewig

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 197 KB

english, 2004

59

High frequency of functionally active Melan-A specific T cells in a patient with progressive immunoproteasome-deficient melanoma

N Meidenbauer, A Zippelius, MJ Pittet, M Laumer, S Vogl, J Heymann, M Rehli, B Seliger, S Schwarz, F-A Le Gal, PY Dietrich, R Andreesen, P Romero, A Mackensen

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 190 KB

english, 2004

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски